These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 24486413

  • 1. Synthesis of a new class of pyrrolo[3,4-h]quinazolines with antimitotic activity.
    Spanò V, Montalbano A, Carbone A, Parrino B, Diana P, Cirrincione G, Castagliuolo I, Brun P, Issinger OG, Tisi S, Primac I, Vedaldi D, Salvador A, Barraja P.
    Eur J Med Chem; 2014 Mar 03; 74():340-57. PubMed ID: 24486413
    [Abstract] [Full Text] [Related]

  • 2. Pyrrolo[3,2-h]quinazolines as photochemotherapeutic agents.
    Barraja P, Caracausi L, Diana P, Montalbano A, Carbone A, Salvador A, Brun P, Castagliuolo I, Tisi S, Dall'Acqua F, Vedaldi D, Cirrincione G.
    ChemMedChem; 2011 Jul 04; 6(7):1238-48. PubMed ID: 21574254
    [Abstract] [Full Text] [Related]

  • 3. Tubulin-dependent hydrolysis of guanosine triphosphate as a screening test to identify new antitubulin compounds with potential as antimitotic agents: application to carbamates of aromatic amines.
    Chi DM, Shahrik LK, Ho HH, Hamel E.
    Cancer Res; 1989 Mar 15; 49(6):1344-8. PubMed ID: 2924291
    [Abstract] [Full Text] [Related]

  • 4. 4'-Alkoxyl substitution enhancing the anti-mitotic effect of 5-(3',4',5'-substituted)anilino-4-hydroxy-8-nitroquinazolines as a novel class of anti-microtubule agents.
    Jin Y, Zhou ZY, Tian W, Yu Q, Long YQ.
    Bioorg Med Chem Lett; 2006 Nov 15; 16(22):5864-9. PubMed ID: 16942876
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Synthesis and biological evaluation of novel 2-(2-arylmethylene)hydrazinyl-4-aminoquinazoline derivatives as potent antitumor agents.
    Jiang N, Zhai X, Zhao Y, Liu Y, Qi B, Tao H, Gong P.
    Eur J Med Chem; 2012 Aug 15; 54():534-41. PubMed ID: 22727449
    [Abstract] [Full Text] [Related]

  • 7. Pyrrolo[3,4-h]quinolinones a new class of photochemotherapeutic agents.
    Barraja P, Diana P, Montalbano A, Carbone A, Viola G, Basso G, Salvador A, Vedaldi D, Dall'Acqua F, Cirrincione G.
    Bioorg Med Chem; 2011 Apr 01; 19(7):2326-41. PubMed ID: 21397509
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Synthesis, in vitro and in vivo preliminary evaluation of anti-angiogenic properties of some pyrroloazaflavones.
    Ferlin MG, Conconi MT, Urbani L, Oselladore B, Guidolin D, Di Liddo R, Parnigotto PP.
    Bioorg Med Chem; 2011 Jan 01; 19(1):448-57. PubMed ID: 21145750
    [Abstract] [Full Text] [Related]

  • 13. Synthesis, modelling, and antimitotic properties of tricyclic systems characterised by a 2-(5-Phenyl-1H-pyrrol-3-yl)-1,3,4-oxadiazole moiety.
    Pinna GA, Murineddu G, Murruzzu C, Zuco V, Zunino F, Cappelletti G, Artali R, Cignarella G, Solano L, Villa S.
    ChemMedChem; 2009 Jun 01; 4(6):998-1009. PubMed ID: 19291736
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and cytotoxicity of 2-phenylquinazolin-4(3H)-one derivatives.
    Rhee HK, Yoo JH, Lee E, Kwon YJ, Seo HR, Lee YS, Choo HY.
    Eur J Med Chem; 2011 Sep 01; 46(9):3900-8. PubMed ID: 21704436
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and antitumor activity of novel 2-(1-substituted-piperidin-4-ylamino)quinazolines as antitumor agents.
    Wang YK, Jin J, Zhu LN, Zhang Y, Chen XG, Gao XQ, Xu BL.
    Yao Xue Xue Bao; 2012 Sep 01; 47(9):1164-78. PubMed ID: 23227546
    [Abstract] [Full Text] [Related]

  • 16. Synthesis of pyrrolo[3,2-h]quinolinones with good photochemotherapeutic activity and no DNA damage.
    Barraja P, Caracausi L, Diana P, Carbone A, Montalbano A, Cirrincione G, Brun P, Palù G, Castagliuolo I, Dall'acqua F, Vedaldi D, Salvador A.
    Bioorg Med Chem; 2010 Jul 01; 18(13):4830-43. PubMed ID: 20627596
    [Abstract] [Full Text] [Related]

  • 17. Synthesis, and docking studies of some fused-quinazolines and quinazolines carrying biological active isatin moiety as cell-cycle inhibitors of breast cancer cell lines.
    Radwan AA, Alanazi FK, Al-Dhfyan A.
    Drug Res (Stuttg); 2013 Mar 01; 63(3):129-36. PubMed ID: 23444171
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and structure-activity relationships of N-methyl-5,6,7-trimethoxylindoles as novel antimitotic and vascular disrupting agents.
    Zhao DG, Chen J, Du YR, Ma YY, Chen YX, Gao K, Hu BR.
    J Med Chem; 2013 Feb 28; 56(4):1467-77. PubMed ID: 23360369
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and biological evaluation of aryloxazole derivatives as antimitotic and vascular-disrupting agents for cancer therapy.
    Choi MJ, No ES, Thorat DA, Jang JW, Yang H, Lee J, Choo H, Kim SJ, Lee CS, Ko SY, Lee J, Nam G, Pae AN.
    J Med Chem; 2013 Nov 27; 56(22):9008-18. PubMed ID: 24160376
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and biological evaluation of (--)-linarinic acid derivatives as neuroprotective agents against OGD-induced cell damage.
    Tian Y, Ma C, Feng L, Zhang L, Hao F, Pan L, Cheng M.
    Arch Pharm (Weinheim); 2012 Jun 27; 345(6):423-30. PubMed ID: 22441681
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.